EPHX1 gene polymorphisms and individual susceptibility to lung cancer.

We investigated the roles of EPHX1 Tyr113His and His139Arg polymorphisms in lung cancer susceptibility in a Finnish study population comprising of 230 lung cancer cases and a large control group (n=2105). The controls were distributed into five age strata, which enabled us to examine the potential age-related changes in the putative EPHX1 at-risk genotypes in the cancer free population. Although the exon 3 slow activity associated allele (His113) containing genotypes posed a decreased lung cancer risk compared with the homozygous wild-type Tyr113/Tyr113 genotype (OR, 0.68; 95% CI, 0.49-0.94), no association was seen for the EPHX1 phenotypes interpreted from the combined exons 3 and 4 genotype data. Neither was any difference seen in the prevalence of the EPHX1 Tyr113His genotypes or interpreted EPHX1 phenotypes in the different age groups.

[1]  J. Zwischenberger,et al.  Effect of epoxide hydrolase polymorphisms on chromosome aberrations and risk for lung cancer. , 2003, Cancer genetics and cytogenetics.

[2]  S. Kudoh,et al.  Overestimated frequency of a possible emphysema-susceptibility allele when microsomal epoxide hydrolase is genotyped by the conventional polymerase chain reaction-based method , 2001, Journal of Human Genetics.

[3]  C. Hassett,et al.  The human microsomal epoxide hydrolase gene (EPHX1): complete nucleotide sequence and structural characterization. , 1994, Genomics.

[4]  F. Gonzalez,et al.  Stereoselective epoxidation and hydration at the K-region of polycyclic aromatic hydrocarbons by cDNA-expressed cytochromes P450 1A1, 1A2, and epoxide hydrolase. , 1996, Biochemistry.

[5]  R. Sram,et al.  Impact of phase I or phase II enzyme polymorphisms on lymphocyte DNA adducts in subjects exposed to urban air pollution and environmental tobacco smoke. , 2003, Toxicology letters.

[6]  F. Oesch,et al.  Interest of genotyping and phenotyping of drug-metabolizing enzymes for the interpretation of biological monitoring of exposure to styrene. , 2002, Pharmacogenetics.

[7]  I. Campbell,et al.  Microsomal epoxide hydrolase polymorphism and susceptibility to ovarian cancer. , 2002, Cancer letters.

[8]  C J Omiecinski,et al.  Epoxide hydrolases: biochemistry and molecular biology. , 2000, Chemico-biological interactions.

[9]  M. Yamakido,et al.  Microsomal epoxide hydrolase genotypes and chronic obstructive pulmonary disease in Japanese. , 2000, International journal of molecular medicine.

[10]  F. Cruellas,et al.  Microsomal epoxide hydrolase and glutathione S-transferase polymorphisms in relation to laryngeal carcinoma risk. , 2002, Cancer letters.

[11]  C. J. Omiecinski,et al.  Human hepatic microsomal epoxide hydrolase: comparative analysis of polymorphic expression. , 1997, Archives of Biochemistry and Biophysics.

[12]  K Trieb,et al.  Association of microsomal epoxide hydrolase polymorphisms and lung cancer risk , 2003, British Journal of Cancer.

[13]  S. Anttila,et al.  Combined effect of polymorphic GST genes on individual susceptibility to lung cancer , 1998, International journal of cancer.

[14]  V. Hosagrahara,et al.  Epoxide hydrolase--polymorphism and role in toxicology. , 2000, Toxicology letters.

[15]  Paolo Boffetta,et al.  Microsomal epoxide hydrolase polymorphisms and lung cancer risk: a quantitative review , 2002, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[16]  J. S. Sidhu,et al.  Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. , 1994, Human molecular genetics.

[17]  P. Dayer,et al.  Association between lung cancer and microsomal epoxide hydrolase genotypes. , 1998, Cancer research.

[18]  D. Christiani,et al.  The interaction between microsomal epoxide hydrolase polymorphisms and cumulative cigarette smoking in different histological subtypes of lung cancer. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[19]  Jack A. Taylor,et al.  Microsomal epoxide hydrolase polymorphism as a risk factor for ovarian cancer , 1996, Molecular carcinogenesis.

[20]  R. Holubkov,et al.  Human peripheral lymphocytes as indicators of microsomal epoxide hydrolase activity in liver and lung. , 1993, Pharmacogenetics.

[21]  M. Thun,et al.  Tobacco smoke and involuntary smoking. , 2004, IARC monographs on the evaluation of carcinogenic risks to humans.

[22]  D. Christiani,et al.  Genetic polymorphisms in N-acetyltransferase-2 and microsomal epoxide hydrolase, cumulative cigarette smoking, and lung cancer. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[23]  A. Rettie,et al.  Functional analysis of human microsomal epoxide hydrolase genetic variants. , 2004, Chemico-biological interactions.

[24]  A. Spurdle,et al.  The microsomal epoxide hydrolase Tyr113His polymorphism: Association with risk of ovarian cancer , 2001, Molecular carcinogenesis.